SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001157523-22-000820
Filing Date
2022-07-06
Accepted
2022-07-06 16:05:57
Documents
13
Period of Report
2022-07-06
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 USANA HEALTH SCIENCES, INC. 8-K a52772859.htm   iXBRL 8-K 26427
2 EXHIBIT 99.1 a52772859ex991.htm EX-99.1 14760
  Complete submission text file 0001157523-22-000820.txt   181500

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA usna-20220706.xsd EX-101.SCH 3914
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE usna-20220706_lab.xml EX-101.LAB 22544
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE usna-20220706_pre.xml EX-101.PRE 16036
7 EXTRACTED XBRL INSTANCE DOCUMENT a52772859_htm.xml XML 4080
Mailing Address 3838 WEST PARKWAY BLVD. 3838 WEST PARKWAY BLVD. SALT LAKE CITY UT 84120-6336
Business Address 3838 WEST PARKWAY BLVD. SALT LAKE CITY UT 84120-6336 8019547100
USANA HEALTH SCIENCES INC (Filer) CIK: 0000896264 (see all company filings)

IRS No.: 870500306 | State of Incorp.: UT | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35024 | Film No.: 221068697
SIC: 2833 Medicinal Chemicals & Botanical Products
Office of Life Sciences